Kiniksa Pharmaceuticals, Ltd. (KNSA)
NASDAQ: KNSA · IEX Real-Time Price · USD
18.45
+0.45 (2.50%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Kiniksa Pharmaceuticals Market Cap
Kiniksa Pharmaceuticals has a market cap or net worth of $1.31 billion as of July 2, 2024. Its market cap has increased by 28.87% in one year.
Market Cap
1.31B
Enterprise Value
1.11B
1-Year Change
28.87%
Ranking
Category
Stock Price
$18.45
Market Cap Chart
Since May 24, 2018, Kiniksa Pharmaceuticals's market cap has increased from $914.40M to $1.31B, an increase of 43.42%. That is a compound annual growth rate of 6.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 1.31B | 6.09% |
| Dec 29, 2023 | 1.23B | 18.44% |
| Dec 30, 2022 | 1.04B | 28.47% |
| Dec 31, 2021 | 810.80M | -32.60% |
| Dec 31, 2020 | 1.20B | 98.17% |
| Dec 31, 2019 | 607.00M | -56.32% |
| Dec 31, 2018 | 1.39B | 51.96% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avadel Pharmaceuticals | 1.36B |
| Nurix Therapeutics | 1.35B |
| ANI Pharmaceuticals | 1.33B |
| Pacira BioSciences | 1.32B |
| AdaptHealth | 1.30B |
| Verona Pharma | 1.26B |
| Spyre Therapeutics | 1.25B |
| Vir Biotechnology | 1.24B |